Clinical Trials Directory

Trials / Unknown

UnknownNCT05330507

Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Convexity Scientific Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective, observational study is designed to investigate clinical outcomes and collect patient feedback on the use of Wellinks, an integrated virtual chronic obstructive pulmonary disease (COPD) management solution, for patients recently discharged from the hospital due to an acute exacerbation of their COPD.

Detailed description

Wellinks, an integrated virtual COPD management solution consists of a combination of health coaching, Bluetooth-connected devices, collection of patient-reported symptoms and medication use, and virtual pulmonary rehabilitation, all centralized by the use of a mobile-phone application (mobile app) downloaded onto a study participant's iOS (iPhone) or Android device. The clinical objectives of this study are to determine whether utilization of Wellinks can reduce the rate of hospital readmissions due to a COPD exacerbation for patients recently discharged from the hospital. The nonclinical objectives of this study are to describe the experience of study participants using Wellinks through the assessment of engagement with the components of Wellinks, as well as by participant-reported satisfaction and perceived value (e.g., willingness to pay). Qualitative feedback on the features and functionality of Wellinks will be solicited.

Conditions

Interventions

TypeNameDescription
OTHERWellinks30-day post-discharge period: virtual respiratory therapist sessions twice per week with synchronous virtual pulmonary rehabilitation and educational materials; at-home use of connected spirometer and pulse oximeter; at-home use of mobile app. 12-week intensive period: virtual health coaching sessions once every two weeks; asynchronous virtual pulmonary rehabilitation program; ongoing access to connected devices (spirometer and pulse oximeter) and mobile app.

Timeline

Start date
2022-07-05
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2022-04-15
Last updated
2023-11-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05330507. Inclusion in this directory is not an endorsement.